NCT04985487Recruiting
Regulatory Post-Marketing Surveillance Study for Brolucizumab
Regulatory Post-Marketing Surveillance (rPMS) Study for Brolucizumab(Beovu ® Injection, Beovu ®Prefilled Syringe)
Source: ClinicalTrials.gov · Last updated 14 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is an open-label, multicenter, single-arm, observational post-marketing surveillance.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 22 Jul 2021
- Start date
- 18 Aug 2021
- Primary completion date
- 14 Jun 2026
- Lead sponsor
- Novartis Pharmaceuticals
- Diseases
- Macular degeneration
- NCT number
- NCT04985487
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 18 Aug 2021 to the primary completion date, 14 Jun 2026
- 13 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients participating in other investigational drug trial
Other illness
- Contraindications as per local prescribing information 1) Hypersensitivity to the active substance or to any of the excipients. 2) Active or suspected ocular or periocular infection. 3) Active intraocular inflammation.
Who the study is looking for
- Patients aged ≥18 years with nAMD that are prescribed with Brolucizumab as per approved local product information
- Patients who consent to participate in the study after the purpose and nature of the study have clearly explained to them (written informed consent)
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (13)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Busan | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Daegu | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Daejeon | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Goyang-si | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Guri-si | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Gwangju | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Iksan Si | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Incheon | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Jeju City | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Pusan | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Suwon | South Korea | Recruiting |
| - Coordinator of this site? Confirm its status | Taegu | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.